Does amantadine have a protective effect against COVID-19?
Open Access
- 1 January 2020
- journal article
- letter
- Published by VM Media Group sp. z o.o in Neurologia i Neurochirurgia Polska
- Vol. 54 (3), 284-285
- https://doi.org/10.5603/PJNNS.a2020.0041
Abstract
Neurologia i Neurochirurgia PolskaKeywords
This publication has 5 references indexed in Scilit:
- Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairmentMultiple Sclerosis and Related Disorders, 2020
- Amantadine as a drug to mitigate the effects of COVID-19Medical Hypotheses, 2020
- What can Parkinson’s disease teach us about COVID-19?Neurologia i Neurochirurgia Polska, 2020
- Potentially repurposing adamantanes for COVID‐19Journal of Medical Virology, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020